Two Sigma Advisers’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,200
| Closed | -$729K | – | 2368 |
|
|
2024
Q4 | $729K | Buy |
+22,200
| New | +$729K | ﹤0.01% | 1613 |
|
|
2024
Q2 | – | Sell |
-20,900
| Closed | -$611K | – | 2422 |
|
|
2024
Q1 | $611K | Buy |
+20,900
| New | +$611K | ﹤0.01% | 1786 |
|
|
2022
Q1 | – | Sell |
-6,400
| Closed | -$210K | – | 2719 |
|
|
2021
Q4 | $210K | Buy |
+6,400
| New | +$210K | ﹤0.01% | 2275 |
|
|
2021
Q2 | – | Sell |
-16,500
| Closed | -$852K | – | 2430 |
|
|
2021
Q1 | $852K | Buy |
+16,500
| New | +$852K | ﹤0.01% | 1737 |
|
|
2020
Q4 | – | Sell |
-38,200
| Closed | -$1.34M | – | 2366 |
|
|
2020
Q3 | $1.34M | Buy |
+38,200
| New | +$1.34M | ﹤0.01% | 1369 |
|
|
2020
Q1 | – | Sell |
-35,100
| Closed | -$1.68M | – | 2445 |
|
|
2019
Q4 | $1.68M | Buy |
+35,100
| New | +$1.68M | ﹤0.01% | 1313 |
|
|
2019
Q3 | – | Sell |
-5,400
| Closed | -$269K | – | 2207 |
|
|
2019
Q2 | $269K | Buy |
+5,400
| New | +$269K | ﹤0.01% | 2048 |
|
|
2019
Q1 | – | Sell |
-34,200
| Closed | -$1.58M | – | 2284 |
|
|
2018
Q4 | $1.58M | Buy |
34,200
+7,300
| +27% | +$337K | ﹤0.01% | 1292 |
|
|
2018
Q3 | $2.08M | Sell |
26,900
-43,500
| -62% | -$3.36M | 0.01% | 1214 |
|
|
2018
Q2 | $5.93M | Sell |
70,400
-21,900
| -24% | -$1.84M | 0.02% | 783 |
|
|
2018
Q1 | $7.55M | Sell |
92,300
-14,500
| -14% | -$1.19M | 0.02% | 693 |
|
|
2017
Q4 | $6.11M | Buy |
106,800
+64,200
| +151% | +$3.67M | 0.02% | 782 |
|
|
2017
Q3 | $2.84M | Buy |
42,600
+200
| +0.5% | +$13.4K | 0.01% | 1042 |
|
|
2017
Q2 | $2.18M | Buy |
42,400
+5,200
| +14% | +$267K | 0.01% | 1158 |
|
|
2017
Q1 | $2.17M | Buy |
37,200
+4,900
| +15% | +$286K | 0.01% | 1214 |
|
|
2016
Q4 | $1.35M | Buy |
32,300
+18,300
| +131% | +$764K | 0.01% | 1392 |
|
|
2016
Q3 | $739K | Buy |
+14,000
| New | +$739K | ﹤0.01% | 1493 |
|